Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

VASOPRESSIN INJECTION USP 20 UNIT

VASOPRESSIN : 20 UNIT · DIN 02247938 · SANDOZ CANADA INCORPORATED

Health Canada status: MARKETED

VASOPRESSIN INJECTION USP 20 UNIT SOLUTION - DIN 02247938
VASOPRESSIN INJECTION USP — DIN 02247938. Product photograph held by Nexara Health.

What is VASOPRESSIN INJECTION USP?

VASOPRESSIN INJECTION USP 20 UNIT contains VASOPRESSIN : 20 UNIT. It is listed in the Health Canada Drug Product Database under DIN 02247938, held by SANDOZ CANADA INCORPORATED, supplied as SOLUTION for INTRAMUSCULAR ; SUBCUTANEOUS administration. Health Canada currently lists it as marketed, status dated 20-Aug-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is VASOPRESSIN INJECTION USP used for?

Vasopressin Injection USP is intended for use in the prevention or treatment of post-operation abdominal distention, dispelling of gas shadows in abdominal roentgenography and symptomatic control of diabetes insipidus.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02247938
Brand nameVASOPRESSIN INJECTION USP
Generic / active ingredientVASOPRESSIN : 20 UNIT
ManufacturerSANDOZ CANADA INCORPORATED
Strength20 UNIT
Dosage formSOLUTION
Route of administrationINTRAMUSCULAR ; SUBCUTANEOUS
SchedulePrescription
ATC codeH01BA01 VASOPRESSIN (ARGIPRESSIN)
AHFS class68:28.00
BiosimilarNo
Health Canada statusMARKETED
Status date20-Aug-2005
Original market date2003-12-10 00:00:00

How is it stored and handled?

Store between 15 and 25 °C. Protect from light and heat. Do not freeze.

How is it supplied?

5 mL multidose vials, boxes of 1

Is VASOPRESSIN (ARGIPRESSIN) in shortage in Canada?

A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by FRESENIUS KABI CANADA LTD, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for VASOPRESSIN INJECTION USP

What can be used instead?

Other Canadian products sharing ATC code H01BA01 VASOPRESSIN (ARGIPRESSIN). 2 of 6 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
VASOPRESSIN INJECTION, USP20 UNITSOLUTIONFRESENIUS KABI CANADA LTDMARKETEDDIN 02139502
PITRESSIN INJ 10 UNIT/0.5ML10 UNIT / .5 MLLIQUIDPARKE-DAVIS DIVISION, WARNER-LAMBERT CANADA INC.CANCELLED POST MARKETDIN 00222577
PRESSYN AR20 UNIT / 1 MLLIQUIDFERRING INCCANCELLED POST MARKETDIN 02246133
VASOPRESSIN INJ 20UNIT/ML USP20 UNITLIQUIDFERRING INCCANCELLED POST MARKETDIN 00693820
VASOPRESSIN INJ 20UNIT/ML USP20 UNITLIQUIDLYPHOMED, DIVISION OF FUJISAWA CANADA INC.CANCELLED POST MARKETDIN 01944800

Who else supplies VASOPRESSIN (ARGIPRESSIN) worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. VASOPRESSIN (ARGIPRESSIN) appears in 9 registered pack listings across 5 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for VASOPRESSIN INJECTION USP

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02247938. Last reviewed 2026-09-09. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.